Editors' Picks
Live Nation - Everybody Wants To Rule The World by Investing 501
Elbit And Modern Warfare: The New Normal by The Tenacious Trader
Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial by PropThink
The Market Embraces AMD's Unifying Plan by Tom Luongo
Hutchinson Technology Reports A Profit And The Future Looks Bright by David Allen
Long Ideas
Magna International - Still Undervalued Near All-Time Highs by Western Investor
Updates On InvenSense's News And Earnings by Esekla
Despite Poor Quarter, ViroPharma's Commercial And Pipeline Progress Continue by PropThink
Facebook: Following Bezos' Strategy To Sacrifice Short-Term Gain For Long-Term Potential by The Value Investor
Intel: Silvermont - The ARM Killer by Russ Fischer
6 Reasons To Buy Advance Auto Parts by Bram de Haas
Tesoro Continues To Create Value As Carson Deal Nears Approval by The Value Investor
Live Nation - Everybody Wants To Rule The World by Investing 501
Is Apple Worth More Dead Than Alive? by Kyle Spencer
EV Energy: Utica Acreage At Firesale Prices by MLP Trader
China's H7N9 Bird Flu And Novavax by Trent MacDonald
First Solar Finds Recovering Competition On The Efficiency Front by Kevin Quon
An Imminent Short Squeeze In Lululemon by StockRiters
A Netflix Bull In Bear's Clothing by Gregory Stuckey
Where Are The Missing PCs? by Paulo Santos
JPMorgan Chase: A Swirl Of Regulatory Woes by John M. Mason
Is Goldman Sachs A Good Investment? by IAEResearch
Anixter's Competitive Advantage: World-Class Customer Service by Nikhil Raheja
Atossa Genetics' Portfolio Can Detect Breast Cancer, But Can These Products Eradicate It? by OneMedPlace
Pandora: Poised For Profit? by Zhen Lu
Harley-Davidson Is Fairly Valued by Kirk DeBaun
Profiting From Markman Hearing Patent Stocks by Stock Investor
Cisco System Inc. Is The Trustworthy Long-Term Investment by Bob Ricco
Elbit And Modern Warfare: The New Normal by The Tenacious Trader
Why Royalty And Milestone Partnership Dynamics Imply Trovagene Could Triple by Logical Assessment
Analyzing DuPont: 3% Yield And Undervalued by Brad Kenagy
Buy Caterpillar: A Global Leader Trading At A Third World Discount by David Trainer
Don't Wait For The Clouds To Clear - Buy ATI Now by Investing 501
Sherwin-Williams: Good Paint, Great Company, Poor Valuation by Mark Kowalski
EMC: A Rewarding Investment? by Catalyst Investments
InvenSense: Growth At An Incredible Price by Stone Fox Capital
GameStop Is Worth $33 But Eighth-Generation Consoles Could Fuel Upside by Trefis
A Look At Prudential's Individual Annuity Business by Trefis
Why Zynga's Recent Results Don't Matter by George Kesarios
VMware And The Health Cloud by Dana Blankenhorn
Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial by PropThink
Growth For Windows Phone In The U.S. Accelerates by Tom Luongo
Durect: Pfizer Hints At Progress With Remoxy by PropThink
Can Nokia Revitalize Feature Phones With New Asha Launches? by Sneha Shah
A Look At Transocean's North Sea Operations by Trefis
Ampio Pharma Initiates Phase III, Investors Extend Momentum by Brian L. Wilson
Short Interest In Nokia Falls Sharply by Jacob Steinberg
Visa's And MasterCard's Growth Marches On As The World Shifts To Plastic by Trefis
NII Holdings: A Raging Buy Emerges From Misread Of EBITDA - $13.13 Target by Tufenk
Why Robert Chapman Is A Better Leading Indicator Of The True Value Of Herbalife Than Bill Ackman by Patent News
A.P. Pharma: Management Change Is A Positive For The Stock by Smith On Stocks
Hess: Activist Investor Providing Push To Unlock Value In Shares by Josh Hutheson
The Market Embraces AMD's Unifying Plan by Tom Luongo
Hutchinson Technology Reports A Profit And The Future Looks Bright by David Allen
Short Ideas
Zynga's Deteriorating Outlook - Time To Move On by Fundamental Analyst
Tesla: The Good, The Realistic And The Ugly Outlook by Odysseus
How To Play The Short Squeeze And When To Cash Out by Adam Betancourt
Billionaire Buffett Trims Moody's Stake, Now It's Your Turn by Marshall Hargrave
LinkedIn Like Microsoft And Baidu - Watch Out Below by George Kesarios
Amazon Has A Moat Without A Castle by Paulo Santos
Vertex Pharmaceuticals Beats Analyst Expectations, Yet Insiders Continue To Sell More Shares by Edward Vranic
Quick Picks & Lists
These Energy Companies May Be The Next Acquisition Targets Of The Chinese Suitors by Value Digger
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential by Life Sciences Report
The ODAC Postmortem: Lessons Learned Part 1, AVEO by PropThink
Derby Extra: Updating The Angles On Our Horse Racing Investments by Stanley Barton
Caterpillar: Buy Now As The Shares Have Bottomed Out by Stock Gamer
Bear Market Coming? Learn From The Last One by John Kozey
Profits Can Be Found In The Expanding And Challenging Medical Isotope Business by The Swiss Trader
Intellectual Property: Hype Or Real Deal? by Dutch Trader
Bear Of The Day: Carpenter Technology by Zacks Investment Research
10 Mid Cap Growth Stocks To Consider For 2013 by Wall Street Wisdom
Sell Apple And Cover TBT by Stock Traders Daily
BlackBerry Browsers Grows 21% In The UK At Apple's Expense, Soon To Overtake Samsung by Michael Collins
Is JPMorgan Chase A Good Investment? by IAEResearch
5 Natural Gas Transportation Stocks For 2013: April Update by Michael Fitzsimmons
U.S. Silica Holdings: Frac Sand Demand Could Power Upside by Bret Jensen
5 Tech Stocks To Buy With Solid Growth Trading Near Lows by David Alton Clark
Investing In The Erin Brockovich Of The Stock Market by Henry Kawabe
China's Geely Now With Kandi Technologies At Low End, Should Look At Tesla For High End by Arthur Porcari
Fund Holdings
What Hedge Funds Are Buying And What To Look For by Alpha Stratus
Insider Ownership
2 Banks And 1 Energy Company With Recent Intensive Insider Buying by Markus Aarnio
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario